Tunny T J, Gordon R D, Klemm S A, Cohn D
Endocrine-Hypertension Research Unit, Greenslopes Hospital, Brisbane, Australia.
Clin Endocrinol (Oxf). 1991 May;34(5):363-9. doi: 10.1111/j.1365-2265.1991.tb00306.x.
Fifteen patients with primary aldosteronism were classified as angiotensin II-unresponsive aldosterone-producing adenoma (AII-U APA, n = 9), or angiotensin II-responsive aldosterone-producing adenoma (AII-R APA, n = 6), based on the responsiveness of aldosterone to upright posture and to angiotensin II infusion. Lack of aldosterone response to angiotensin II infusion immediately postoperatively in the AII-R APA subtype was consistent with previous responsiveness residing solely within the adenoma. Cortisol levels in five of the six patients with AII-R APA failed to suppress normally with dexamethasone consistent with some autonomous production of cortisol by the adenoma. In contrast, cortisol levels suppressed normally during dexamethasone administration in all patients with AII-U APA. This biochemical distinction can be added to the previously described overproduction of 18-oxo cortisol in AII-U APA but not in AII-R APA. Histological examination of adenoma sections revealed predominantly (greater than or equal to 50%) zona fasciculata type cells in AII-U APA. In contrast, AII-R APA contained less than 20% zona fasciculata type. Thus, biochemical differences between AII-U APA and AII-R APA subtypes of primary aldosteronism may be due to underlying differences in cellular composition of the aldosterone-producing adenomas.
根据醛固酮对直立姿势和血管紧张素II输注的反应性,将15例原发性醛固酮增多症患者分为血管紧张素II无反应性醛固酮瘤(AII-U APA,n = 9)或血管紧张素II反应性醛固酮瘤(AII-R APA,n = 6)。AII-R APA亚型术后即刻对血管紧张素II输注缺乏醛固酮反应,这与之前仅腺瘤内存在反应性一致。6例AII-R APA患者中有5例的皮质醇水平不能被地塞米松正常抑制,这与腺瘤自主分泌一些皮质醇一致。相比之下,所有AII-U APA患者在地塞米松给药期间皮质醇水平均正常抑制。这种生化差异可补充到先前描述的AII-U APA中18-氧代皮质醇分泌过多而AII-R APA中没有这一情况。腺瘤切片的组织学检查显示,AII-U APA中主要(大于或等于50%)为束状带型细胞。相比之下,AII-R APA中束状带型细胞少于20%。因此,原发性醛固酮增多症的AII-U APA和AII-R APA亚型之间的生化差异可能是由于醛固酮瘤细胞组成的潜在差异。